Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL73997 | 1.00 | — | — | |
| SCHEMBL74607 | 1.00 | — | — | |
| SCHEMBL42054 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL6545802 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL30716856 | 0.96 | — | — | |
| SCHEMBL29399187 | 0.96 | — | — | |
| Hydrogen Peroxide SCHEMBL11422902 | 0.96 | — | — | |
| Charcoal, Activated SCHEMBL12487647 | 0.96 | — | — | |
| Isopropyl Alcohol SCHEMBL16321076 | 0.96 | TP53 (0.53) | TP53LMNAALDH1A1TSHRTDP1 | |
| Butanedione SCHEMBL2403188 | 0.92 | TSHR (0.54) | TP53LMNAALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3634939-A1 | METHODS OF MAKING COMPOUNDS HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | Eastman Chemical Company (US) | 2020-04-15 | — | — | EP | claimed |
| US-10160718-B2 | Methods of making compounds having antidegradant and antifatigue efficacy | EASTMAN CHEMICAL COMPANY (US) | 2018-12-25 | — | — | US | claimed |
| WO-2018226372-A1 | METHODS OF MAKING COMPOUNDS HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | EASTMAN CHEMICAL COMPANY (US) | 2018-12-13 | — | — | WO | claimed |
| US-20170275234-A1 | METHODS OF MAKING COMPOUNDS HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | EASTMAN CHEMICAL COMPANY (US) | 2017-09-28 | — | — | US | claimed |
| US-11062794-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| EP-3064066-B1 | METHOD FOR CHANGING THE DEVELOPMENT PATTERN, INCREASING THE GROWTH AND THE ACCUMULATION OF STARCH, CHANGING THE STRUCTURE OF STARCH AND INCREASING THE RESISTANCE TO WATER STRESS IN PLANTS | TIMAC AGRO ESPANA S A (ES) | 2021-05-19 | — | — | EP | disclosed |
| CN-106434461-B | One plant of strains of streptococcus thermophilus and application thereof | 内蒙古农业大学 | 2019-05-14 | — | — | CN | disclosed |
| CN-109679885-A | One plant increases the lactobacillus plantarum of 3- hydroxy-2-butanone content and its application in soy sauce | 佛山市海天(高明)调味食品有限公司 | 2019-04-26 | — | — | CN | disclosed |
| CN-109370958-A | One plant increases the lactobacillus plantarum of 3- hydroxy-2-butanone content and its application in soy sauce | 佛山市海天(高明)调味食品有限公司 | 2019-02-22 | — | — | CN | disclosed |
| CN-105603025-B | A kind of fermentation method for producing of coproduction uridine and 3-hydroxy-2-butanone | 天津科技大学 | 2019-01-04 | — | — | CN | disclosed |
| US-20180253534-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-09-06 | — | — | US | disclosed |
| EP-3365418-A2 | PARTICLES FOR MALODOR REDUCTION | The Procter and Gamble Company (US) | 2018-08-29 | — | — | EP | disclosed |
| US-20110014322-A1 | TASTE AND FLAVOR MODULATION BY BIOTRANSFORMATION IN MILK PRODUCTS | Société des Produits Nestlé S.A. (CH) | 2011-01-20 | — | — | US | disclosed |
| US-20100143561-A1 | PET FOOD AND A PROCESS FOR ITS MANUFACTURE | MARS INCORPORATED (US) | 2010-06-10 | — | — | US | disclosed |
| EP-2144513-A2 | PET FOOD AND A PROCESS FOR ITS MANUFACTURE | Mars Incorporated (US) | 2010-01-20 | — | — | EP | disclosed |
| CN-101631566-A | Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same | KEMPHARM INC | 2010-01-20 | — | — | CN | disclosed |
| WO-2009091375-A9 | RAPID DETECTION OF VOLATILE ORGANIC COMPOUNDS FOR IDENTIFICATION OF BACTERIA IN A SAMPLE | THE CHARLES STARK DRAPER LABORATORY, INC. (US) | 2009-09-11 | — | — | WO | disclosed |
| WO-2009091375-A2 | RAPID DETECTION OF VOLATILE ORGANIC COMPOUNDS FOR IDENTIFICATION OF BACTERIA IN A SAMPLE | THE CHARLES STARK DRAPER LABORATORY, INC. (US) | 2009-07-23 | — | — | WO | disclosed |
| WO-2008135180-A2 | PET FOOD AND A PROCESS FOR ITS MANUFACTURE | MARS INCORPORATED (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2007038524-A2 | COCRYSTALLIZATION METHODS | SSCI, INC. (US) | 2007-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275234-A1 | METHODS OF MAKING COMPOUNDS HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | ACHE, HNMT, PNMT | TP53 2453/4885LMNA 2406/4885ALDH1A1 603/4885 |
| US-10160718-B2 | Methods of making compounds having antidegradant and antifatigue efficacy | ACHE, HNMT, PNMT | TP53 2453/4885LMNA 2406/4885ALDH1A1 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.